Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
Recruiting · NCT05407987 · Registry updated 2025-04-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) | Anemia, Hypochromic, Hemic and Lymphatic Diseases, Iron Deficiencies, Nutritional and Metabolic Diseases, anemia, female reproductive organ cancer, hematologic disorder, iron deficiency anemia, iron metabolism disease, metabolic disease | Recruiting | Phase 3 | 2025-04-25 | NCT05407987 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AHS Cancer Control Alberta | 37 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Arthur J.E. Child Comprehensive Cancer Centre | Calgary | Canada | 45 |